{"id":5184,"date":"2021-11-19T08:46:02","date_gmt":"2021-11-19T08:46:02","guid":{"rendered":"https:\/\/osmr.ro\/?p=5184"},"modified":"2021-11-19T08:47:16","modified_gmt":"2021-11-19T08:47:16","slug":"validarea-snvm-core-1-09-reporting-tool-1-06","status":"publish","type":"post","link":"https:\/\/osmr.ro\/en\/validarea-snvm-core-1-09-reporting-tool-1-06\/","title":{"rendered":"NMVS Core 1.09 &#038; Reporting Tool 1.06 Validation"},"content":{"rendered":"<p><strong>Protecting patients\u2019 safety by guaranteeing access to authentic medicines is the fundamental objective of each National Medicines Verification Organisation (NMVO).<\/strong> Thus, maintaining a functional and robust medicines verification system across Europe through continuous improvement is a priority for all NMVOs.<\/p>\n<p>OSMR has been involved in the European Working Groups since their establishment, understanding the importance of a collaborative working environment.<\/p>\n<p>Such Working Groups are the ones testing the system\u2019s new releases. <strong>For the latest National Medicines Verification System (NMVS) new versions deployment: NMVS Core \u2013 1.09 &amp; Reporting Tool \u2013 1.06, three testing phases have been executed.<\/strong><\/p>\n<p>Firstly, the <strong>joint User Acceptance Test (jUAT)<\/strong> where the latest software versions of NMVS Core &amp; Reporting Tool are tested for compliance. For the NMVS Core 1.09 &amp; Reporting Tool 1.06 Release there were 6 NMVOs involved: <strong>Latvia, Romania (<em>Dan Vi\u0219oiu \u2013 Test Engineer and Elena Georgescu \u2013 QA Representative),<\/em> Hungary, Portugal, The Netherlands and Germany<\/strong>.<\/p>\n<p>During this testing phase (<strong>12.07 \u2013 30.07.2021<\/strong>), two initial application versions were rejected due to major defects and the 3<sup>rd<\/sup> application release was accepted after fixing and retesting the initial defects.<\/p>\n<p>Furthermore, there were 2 pilot countries where the 1.09 Release has been installed and tested for the <strong>jUAT Group \u2013 Romania and the Netherlands<\/strong>.<\/p>\n<p>Secondly, there is the <strong>Inter-Operability Testing (IOT)<\/strong> which focuses on testing and validating the inter-operability between EMVO, the Arvato Ecosystem and the Solidsoft (SSR) Ecosystem. For this second testing phase (<strong>24.08 \u2013 03.09.2021<\/strong>) coordinated by the European Medicines Verification Organisation (EMVO), the following NMVOs were involved: <strong>Latvia, Romania (<em>Dan Vi\u0219oiu \u2013 Test Engineer<\/em>), Hungary, Portugal, Germany, Belgium, Denmark, Austria.<\/strong><\/p>\n<p>After running the tests and completing the validation, the application was admitted for implementation in the Production Environment.<\/p>\n<p>The 2 pilot countries where the 1.09 Release has been installed and tested for the <strong>IOT Group \u2013 Romania and Germany.<\/strong><\/p>\n<p>Lastly, the final stage of the acceptance process for the NMVS Core 1.09 Release was the <strong>local testing<\/strong> (<strong>NMVS Core 1.09 \u2013 08.11-09.11.2021<\/strong> &amp; <strong>Reporting Tool 1.06 \u2013 06.10-11.10.2021<\/strong>) where 6 more defects were identified, fixed and retested.<\/p>\n<p><strong>For this last testing phase Romania was the country that volunteered to perform the tests and it was represented by <em>Mihai P\u0103duraru \u2013 Test Engineer<\/em>, member of the OSMR Team.<\/strong><\/p>\n<p><img class=\"lazyload\" decoding=\"async\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%271471%27%20height%3D%27855%27%20viewBox%3D%270%200%201471%20855%27%3E%3Crect%20width%3D%271471%27%20height%3D%27855%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/osmr.ro\/wp-content\/uploads\/2021\/11\/pic-EN-1.png\" alt=\"\" title=\"-\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Protecting patients\u2019 safety by guaranteeing access to authentic medicines is the fundamental objective of each <a href=\"https:\/\/osmr.ro\/en\/validarea-snvm-core-1-09-reporting-tool-1-06\/\"> [&#8230;]<\/a><\/p>\n","protected":false},"author":6,"featured_media":5200,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-5184","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stiri"],"translation":{"provider":"WPGlobus","version":"3.0.3","language":"en","enabled_languages":["ro","en"],"languages":{"ro":{"title":true,"content":true,"excerpt":false},"en":{"title":true,"content":true,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/posts\/5184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/comments?post=5184"}],"version-history":[{"count":17,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/posts\/5184\/revisions"}],"predecessor-version":[{"id":5210,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/posts\/5184\/revisions\/5210"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/media\/5200"}],"wp:attachment":[{"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/media?parent=5184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/categories?post=5184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/osmr.ro\/en\/wp-json\/wp\/v2\/tags?post=5184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}